Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/1999

01-07-1999 | Original Article

Prognostic relevance of tn expression in Breast Cancer

Authors: Atsuo Tsuchiya, Masahiko Kanno, Takanori Kawaguchi, Yoshiyuki Endo, Guo-Jun Zhang, Tohru Ohtake, Izo Kimijima

Published in: Breast Cancer | Issue 3/1999

Login to get access
Metadata
Title
Prognostic relevance of tn expression in Breast Cancer
Authors
Atsuo Tsuchiya
Masahiko Kanno
Takanori Kawaguchi
Yoshiyuki Endo
Guo-Jun Zhang
Tohru Ohtake
Izo Kimijima
Publication date
01-07-1999
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/1999
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967164

Other articles of this Issue 3/1999

Breast Cancer 3/1999 Go to the issue

Editorial

Is the value of regional lymph node dissection different in Breast Cancer ana Gastrointestinal Cancer?

Case Report

Consecutively occurring multiple fibroadenomas of the breast distinguished from phyllodes tumors by clonality analysis of stromal tissue

Letters to the Editor

Transforming growth factor beta related to extent of tumor angiogenesis but not apoptosis or proliferation in breast carcinoma

Review Article

The sentinel node for staging breast cancer: Current review

Original Article

Tumor marker levels elevate false-positively in postsurgical Breast Cancer patients with high sgpt levels or with receiving oral 5-FU or its derivatives

Letters to the Editor

Authors’ reply
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits